Exploration of Targeted Anti-tumor Therapy

Open Access Review

Antibody-drug conjugates: beyond current approvals and potential future strategies

Siddharth Menon ... Hui K. Gan

Published: April 28, 2022 Explor Target Antitumor Ther. 2022;3:252–277

DOI: https://doi.org/10.37349/etat.2022.00082

This article belongs to the special issue Antibody-Drug Conjugates

Full Text PDF

8734 248 17

Open Access Perspective

Endocrine resistant breast cancer: brain metastasis

Matthew Willman ... Brandon Lucke-Wold

Published: April 26, 2022 Explor Target Antitumor Ther. 2022;3:240–251

DOI: https://doi.org/10.37349/etat.2022.00081

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

2972 45 9

Open Access Original Article

The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer

Samuel Jones ... Kathryn M. Taylor

Published: April 26, 2022 Explor Target Antitumor Ther. 2022;3:224–239

DOI: https://doi.org/10.37349/etat.2022.00080

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

3897 90 2

Open Access Review

Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy

Marianeve Carotenuto ... Nicola Normanno

Published: April 26, 2022 Explor Target Antitumor Ther. 2022;3:200–223

DOI: https://doi.org/10.37349/etat.2022.00079

This article belongs to the special issue Precision Medicine for Cholangiocarcinoma

Full Text PDF

5940 91 17

Open Access Review

Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic

Aglaia Skolariki ... Simon Lord

Published: April 24, 2022 Explor Target Antitumor Ther. 2022;3:172–199

DOI: https://doi.org/10.37349/etat.2022.00078

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

5238 104 14

Open Access Review

Advancing antibody-drug conjugates in gynecological malignancies: myth or reality?

Marta Nerone ... Ilaria Colombo

Published: April 19, 2022 Explor Target Antitumor Ther. 2022;3:149–171

DOI: https://doi.org/10.37349/etat.2022.00077

This article belongs to the special issue Antibody-Drug Conjugates

Full Text PDF

6404 140 5

Open Access Review

Yeast as a tool to decipher the molecular mechanisms underlying the functions of Bcl-2 family

Stéphen Manon

Published: April 02, 2022 Explor Target Antitumor Ther. 2022;3:128–148

DOI: https://doi.org/10.37349/etat.2022.00076

This article belongs to the special issue The Role of Bcl-2 Family Proteins in Cancer Progression and Their Relevance to Cancer Therapy

Full Text PDF

2907 49 7

Open Access Review

Polyester materials for mRNA delivery

Wang Chen ... Dandan Zhu

Published: March 11, 2022 Explor Target Antitumor Ther. 2022;3:117–127

DOI: https://doi.org/10.37349/etat.2022.00075

This article belongs to the special issue Gene Delivery Approach to Fight Cancer

Full Text PDF

3664 133 8